Litcius/Paper detail

Coexpression of ΔNp63/p40 and TTF1 Within Most of the Same Individual Cells Identifies Life-Threatening NSCLC Featuring Squamous and Glandular Biphenotypic Differentiation: Clinicopathologic Correlations

Giuseppe Pelosi, Matteo Bulloni, Martina Vescio, Silvia Uccella, Fabien Forest, Giorgia Leone, Massimo Barberis, Daoud Rahal, Paola Bossi, Giovanna Finzi, Deborah Marchiori, Marco De Luca, Fausto Sessa, Sergio Harari, Manuela Spinelli, Patrizia Viola, Paolo Macrì, Stefania Maria, Antonio Rizzo, Antonio Picone, Linda Pattini

2021JTO Clinical and Research Reports10 citationsDOIOpen Access PDF

Abstract

Introduction: Double occurrence of TTF1 and ΔNp63/p40 (henceforth, p40) within the same individual cells is exceedingly rare in lung cancer. Little is known on their biological and clinical implications. Methods: Two index cases immunoreactive for both p40 and TTF1 and nine tumors selected from The Cancer Genome Atlas (TCGA) according to the mRNA levels of the two relevant genes entered the study. Results: copy number variations on next-generation sequencing analysis. The nine tumors from TCGA (0.88% of 1018 tumors) shared the same poor prognosis, clinical presentation, and challenging histology and had activated pathways of enhanced angiogenesis and epithelial-mesenchymal transition. Mutation and copy number variation profiles did not differ from the other TCGA tumors. Conclusions: Double p40+/TTF1+ lung carcinomas are aggressive and likely underrecognized non-small cell carcinomas, whose origin could reside in double-positive distal airway stem-like basal cells through either de novo-basal-like or differentiating cell mechanisms according to a model of epithelial renewal.

Topics & Concepts

BiologyCancer researchPathologyMedicineLung Cancer Treatments and MutationsLung Cancer Diagnosis and TreatmentGenomic variations and chromosomal abnormalities